ClinicalTrials.gg
RecruitingNCT07838025Updated Sep 24, 2026

AirGo™ Respiratory Monitoring in Lung Resection

An interventional study of AirGoTM system in Respiratory Monitoring, Thoracic Surgery and Lung Resection Surgery, sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia. Recruiting at 1 site in Italy. Open to participants aged 21 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Apr 2026, registered Sep 2026).
  • Started Apr 2026; still recruiting 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
21 Years to 80 Years
Sex
All
01

Study summary

Patients undergoing lung resection surgery may experience changes in respiratory function during the perioperative period. Current monitoring methods provide important clinical information but are often limited to specific time points and may not allow continuous assessment of ventilation. This study aims to evaluate the feasibility and usefulness of the AirGo™ wearable respiratory monitoring system in patients undergoing anatomical lung resection (lobectomy or segmentectomy). AirGo™ is a non-invasive, CE-marked device that continuously measures respiratory parameters, including minute ventilation and respiratory rate, through a chest-worn sensor. Participants will wear the AirGo™ device before surgery and during the postoperative period. Respiratory parameters collected by AirGo™ will be analyzed at predefined time points and compared with standard clinical monitoring methods routinely used in postoperative care, including pulse oximetry and telemetry. The primary objective is to assess changes in mean minute ventilation from the preoperative period to the first postoperative day. Secondary objectives include evaluating perioperative respiratory trends, patient comfort and compliance with the device, and the agreement between AirGo™ measurements and standard monitoring systems. The results of this study may help determine whether continuous non-invasive respiratory monitoring can improve the assessment and management of patients undergoing lung surgery.

02

Conditions studied

  • Respiratory Monitoring
  • Thoracic Surgery
  • Lung Resection Surgery
  • Respiratory Function
  • Perioperative Monitoring
03

In context

Lead sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia is the lead sponsor of 257 studies on the registry; 114 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients scheduled for minimally invasive anatomical lung resection, specifically Video-Assisted thoracic surgery (VATS) lobectomy or segmentectomy, performed for diagnostic or curative purposes;
  • Patients capable of performing a spirometry
  • Age between 21 and 80 years
  • Patient consented to the study by signing the consent

Exclusion criteria

Exclusion Criteria:

  • Pre-operative presence of pneumothorax and/or pleural effusion
  • Pregnancy
  • Severe trauma or major surgery in the last year previous cardio-thoracic surgery (including spinal surgery)
  • Preoperative chest pain or low back pain,
  • Obesity ( >30)
  • Emergency surgery
  • Patients scheduled for anatomical lung resection
  • Specifically thoracotomy lobectomy or segmentectomy
  • Scheduled bi-lobectomy or pneumonectomy or extended sleeve lobectomy
  • Lung resection extended to the chest wall
  • Inability to follow procedures
  • Insufficient knowledge of project language (italian)
  • Inability to give consent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    AirGo Respiratory Monitoring

    Participants undergoing minimally invasive anatomical lung resection (VATS, lobectomy or segmentectomy) will undergo perioperative respiratory monitoring using the AirGo™ device in addition to standard clinical care. Respiratory parameters, including minute ventilation and respiratory rate, will be assessed at predefined timepoints before and after surgery.

    Device: AirGoTM system

Interventions

  • DeviceAirGoTM system

    AirGo™ is a non-invasive wireless wearable respiratory monitoring system used for continuous measurement of respiratory parameters, including minute ventilation and respiratory rate, during the perioperative period.

06

What researchers measure

Primary outcomes

  1. Change in Mean Minute Ventilation

    Difference in mean minute ventilation (L/min), measured by the AirGo™ system during a 60-minute resting recording, between the preoperative assessment and the first postoperative day.

    Time frame: From preoperative baseline to the first postoperative day

Secondary outcomes

  1. Change in Mean Minute Ventilation Over Perioperative Timepoints

    Change in mean minute ventilation (L/min) measured by the AirGo™ system at preoperative baseline, first postoperative day, second postoperative day, and one month after surgery

    Time frame: Preoperative baseline, first postoperative day, second postoperative day, and one month after intervention

  2. Change in Mean Resting Respiratory Rate

    Change in mean resting respiratory rate (breaths/min) measured by continuous AirGo™ monitoring at preoperative baseline, first postoperative day, second postoperative day, and one month after surgery.

    Time frame: Preoperative baseline, first postoperative day, second postoperative day, and one month after intervention

  3. Patient-Reported Comfort With AirGo™ Monitoring

    Patient-reported comfort during AirGo™ monitoring assessed using a standardized Numerical Rating Scale (NRS)

    Time frame: During the postoperative period

  4. Agreement Between AirGo™ and Standard Postoperative Monitoring for Respiratory Rate

    Agreement between respiratory rate measured by the AirGo™ system and respiratory rate obtained from standard postoperative monitoring, including pulse oximetry and telemetry, during overlapping observation periods.

    Time frame: During the postoperative monitoring period on postoperative days 1 and 2

  5. AirGo™ Device-Related Adverse Events

    Number of participants experiencing device-related adverse events, including skin irritation, discomfort, interference with surgical wounds, and premature discontinuation of monitoring.

    Time frame: From device application through 1 month after intervention

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07838025
Responsible party
Arianna Farronato (Principal Investigator, Fondazione IRCCS Policlinico San Matteo di Pavia) — Principal investigator
First posted
Sep 24, 2026
Start date
Apr 7, 2026
Primary completion
Apr 2028 (estimated)
Completion
Apr 2028 (estimated)
Last update
Sep 24, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion